In this module, Komal Jhaveri, MD, FACP, reviews strategies to achieve optimal outcomes and significantly improve quality of life for patients with previously treated advanced breast cancer who are receiving antibody drug conjugates.
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/safety-of-adcs-in-mbc-module/18633-27284
- Start Date: 2024-02-07 06:00:00
- End Date: 2024-02-07 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 40000.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 40000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest